Joshua Roeland

340b Financial Analyst I | Dallas, Texas, United States

Professional Overview

Joshua Roeland is a dedicated 340b Financial Analyst with a strong background in the healthcare industry. He brings a unique blend of technical expertise and industry knowledge to his current role, where he is responsible for analyzing and optimizing 340b drug pricing programs to ensure compliance and maximize cost savings for CHRISTUS Health.

Experience Summary

Current Role

Joshua currently serves as a 340b Financial Analyst I at CHRISTUS Health, a leading not-for-profit health system. In this role, he is responsible for:

• Analyzing 340b drug pricing data to identify potential savings and optimize program performance

• Ensuring compliance with complex 340b regulations and guidelines

• Collaborating with cross-functional teams to implement process improvements and drive operational efficiency

• Providing detailed reporting and insights to support strategic decision-making

Career Progression

Prior to his current role, Joshua gained valuable experience as a Certified Pharmacy Technician at UT Southwestern Medical Center and UT Health East Texas, where he developed a deep understanding of pharmacy operations and the 340b program. He also worked as a Pharmacy Technician at CVS Pharmacy and a Lab Tech at Eyemart Express, further expanding his healthcare and customer service expertise.

Academic Background

Joshua holds a high school diploma and is a Certified Pharmacy Technician, demonstrating his commitment to continuous learning and professional development within the healthcare field.

Areas of Expertise

• 340b drug pricing program management

• Financial analysis and reporting

• Regulatory compliance and risk mitigation

• Pharmacy operations and workflow optimization

• Cross-functional collaboration and project management

Professional Impact

Throughout his career, Joshua has contributed to the success of various healthcare organizations by:

• Implementing process improvements that led to more efficient 340b program management and cost savings

• Ensuring compliance with complex 340b regulations, minimizing the risk of audits and penalties

• Leveraging data-driven insights to inform strategic decision-making and drive operational excellence

Conclusion

With his diverse healthcare experience, technical proficiency, and commitment to continuous improvement, Joshua Roeland is well-positioned to continue making a positive impact as a 340b Financial Analyst at CHRISTUS Health. He is dedicated to exploring new opportunities to enhance the efficiency and effectiveness of 340b drug pricing programs, ultimately contributing to improved patient outcomes and the overall success of the organization.